Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Waldenstrom Macroglobulinemia × Vinorelbine × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 9 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Rhabdomyosarcoma 2 Recurrence 2 Neoplasm Metastasis 2 Hodgkin Disease 2 Adenocarcinoma 2 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Neoplasms 1 NSCLC 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1 Locally Advanced Non-Small Cell Lung Cancer 1 Carcinoma, Squamous Cell 1 Carcinoma, Large Cell 1

Interventions

zanubrutinib 7 Rituximab 7 ibrutinib 4 venetoclax 3 ixazomib 3 pirtobrutinib 2 Specimen Handling 2 Prednisone 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 CT-P10 2 Bortezomib 2 Biopsy 2 talquetamab 1 fludarabine 1 brexucabtagene autoleucel 1 acalabrutinib 1 Vincristine 1 Valganciclovir 1 Valacyclovir 1 Therapeutics 1 Thalidomide 1 Sirolimus 1 Polymerase Chain Reaction 1 Pharmacogenomic Variants 1 Lenalidomide 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡